33664584|t|Dysiarenone from Marine Sponge Dysidea arenaria Attenuates ROS and Inflammation via Inhibition of 5-LOX/NF-kappaB/MAPKs and Upregulation of Nrf-2/OH-1 in RAW 264.7 Macrophages.
33664584|a|BACKGROUND: Marine natural products harbor a variety of pharmacological activities, and the sea species have been becoming a main source of new drug candidate. In pursuit of safer and more effective anti-inflammation drug, the anti-inflammatory activities, anti-oxygenation effects and underlying molecular mechanisms of compound dysiarenone from Dysidea arenaria were investigated via LPS-induced RAW 264.7 cell model. METHODS: Firstly, RAW 264.7 cells have been stimulated with LPS and treated with dysiarenone, and the cell viability of the LPS-treated RAW 264.7 cells was examined. One-step method, DCFH-DA fluorescence probe method was used to detect reactive oxygen species (ROS). The modulation of dysiarenone on anti-inflammation was detected by enzyme-linked immunosorbent assay by measuring the release of inflammatory cytokines (TNF-alpha and IL-6), and inflammatory mediators (LTB4). Further, the underlying anti-inflammatory mechanism of dysiarenone was explored by determining the expression of inducible 5-LOX, MAPKs, p-Akt, and p-NF-kappaB p65. Oxidative stress is tightly connected with inflammation, which was also evaluated through nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (OH-1) signaling pathway. RESULTS: Our study unraveled that dysiarenone between 2 and 8 microM reduces the inflammation responses via suppressing the production of inflammatory cytokines (TNF-alpha and IL-6) and inflammatory mediators (LTB4). Dysiarenone down-regulated the protein levels of inducible 5-LOX via the inhibition of phosphorylation of MAPKs (including p38, ERK), Akt and NF-kappaB p65. Additionally, dysiarenone decreases ROS accumulation by upregulating HO-1 expression via nuclear translocation of Nrf2. CONCLUSION: In conclusion, we demonstrated that dysiarenone possesses anti-inflammation and anti-oxidation activity via inhibiting 5-LOX/NF-kappaB/MAPK and Nrf2/HO-1 signaling pathway. Dysiarenone might be a promising lead compound for inflammatory diseases.
33664584	0	11	Dysiarenone	Chemical	-
33664584	24	30	Sponge	Species	
33664584	31	47	Dysidea arenaria	Species	1147784
33664584	59	62	ROS	Chemical	MESH:D017382
33664584	67	79	Inflammation	Disease	MESH:D007249
33664584	98	103	5-LOX	Gene	11689
33664584	104	113	NF-kappaB	Gene	18033
33664584	140	145	Nrf-2	Gene	18024
33664584	154	163	RAW 264.7	CellLine	CVCL:0493
33664584	381	393	inflammation	Disease	MESH:D007249
33664584	409	421	inflammatory	Disease	MESH:D007249
33664584	507	518	dysiarenone	Chemical	-
33664584	524	540	Dysidea arenaria	Species	1147784
33664584	563	566	LPS	Chemical	MESH:D008070
33664584	575	584	RAW 264.7	CellLine	CVCL:0493
33664584	615	624	RAW 264.7	CellLine	CVCL:0493
33664584	657	660	LPS	Chemical	MESH:D008070
33664584	678	689	dysiarenone	Chemical	-
33664584	721	724	LPS	Chemical	MESH:D008070
33664584	733	742	RAW 264.7	CellLine	CVCL:0493
33664584	780	787	DCFH-DA	Chemical	MESH:C029569
33664584	833	856	reactive oxygen species	Chemical	MESH:D017382
33664584	858	861	ROS	Chemical	MESH:D017382
33664584	882	893	dysiarenone	Chemical	-
33664584	902	914	inflammation	Disease	MESH:D007249
33664584	993	1005	inflammatory	Disease	MESH:D007249
33664584	1017	1026	TNF-alpha	Gene	21926
33664584	1031	1035	IL-6	Gene	16193
33664584	1042	1054	inflammatory	Disease	MESH:D007249
33664584	1102	1114	inflammatory	Disease	MESH:D007249
33664584	1128	1139	dysiarenone	Chemical	-
33664584	1196	1201	5-LOX	Gene	11689
33664584	1212	1215	Akt	Gene	11651
33664584	1281	1293	inflammation	Disease	MESH:D007249
33664584	1328	1371	nuclear factor erythroid 2-related factor 2	Gene	18024
33664584	1373	1377	Nrf2	Gene	18024
33664584	1379	1395	heme oxygenase-1	Gene	15368
33664584	1456	1467	dysiarenone	Chemical	-
33664584	1503	1515	inflammation	Disease	MESH:D007249
33664584	1560	1572	inflammatory	Disease	MESH:D007249
33664584	1584	1593	TNF-alpha	Gene	21926
33664584	1598	1602	IL-6	Gene	16193
33664584	1608	1620	inflammatory	Disease	MESH:D007249
33664584	1639	1650	Dysiarenone	Chemical	-
33664584	1698	1703	5-LOX	Gene	11689
33664584	1762	1765	p38	Gene	26416
33664584	1767	1770	ERK	Gene	26413
33664584	1773	1776	Akt	Gene	11651
33664584	1810	1821	dysiarenone	Chemical	-
33664584	1832	1835	ROS	Chemical	MESH:D017382
33664584	1865	1869	HO-1	Gene	15368
33664584	1910	1914	Nrf2	Gene	18024
33664584	1964	1975	dysiarenone	Chemical	-
33664584	1991	2003	inflammation	Disease	MESH:D007249
33664584	2047	2052	5-LOX	Gene	11689
33664584	2053	2062	NF-kappaB	Gene	18033
33664584	2072	2076	Nrf2	Gene	18024
33664584	2077	2081	HO-1	Gene	15368
33664584	2101	2112	Dysiarenone	Chemical	-
33664584	2152	2173	inflammatory diseases	Disease	MESH:D007249
33664584	Association	MESH:D007249	26413
33664584	Association	11689	26413
33664584	Association	MESH:D007249	15368
33664584	Association	MESH:D007249	11689
33664584	Association	MESH:D007249	18024
33664584	Association	MESH:D007249	21926
33664584	Association	11651	11689
33664584	Association	11689	26416
33664584	Association	MESH:D007249	16193
33664584	Association	15368	18024
33664584	Association	MESH:D007249	26416
33664584	Association	MESH:D007249	18033
33664584	Association	MESH:D017382	15368

